全球首款!博安生物“度拉糖肽生物类似药”获批上市

医药魔方Info
Aug 08

8月8日,国家药监局(NMPA)官网显示,绿叶制药旗下公司博安生物的度拉糖肽注射液(BA5101,LY05008)获批上市,用于成人2型糖尿病患者的血糖控制。这是首款获批上市的国产度拉糖肽生物类似药。原研度拉糖肽是礼来开发的一种长效GLP-1受体激动剂,注射频率为每周1次。与其他类型的降糖药相比,度拉糖肽可改善胰岛β细胞的功能,稳定、有效地降低血糖及糖化血红蛋白(HbA1c)水平。此外,该产品不易...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10